Khalil 2016.
Study characteristics | ||
Methods |
Study design: RCT, parallel‐group design with one study eye per child Number randomized (total and per group): 28 eyes of 28 children; 14 in each group Number analyzed (total and per group): 28 eyes of 28 children; 14 in each group Losses to follow‐up: not reported Length of follow‐up: Planned: 3 years Actual: 3 years Sample size calculation (Y/N): Y (details of sample size and power not reported) |
|
Participants |
Country: Egypt Age: trabeculotomy: 6.52 ± 3.89 months; combined trabeculotomy–trabeculectomy with mitomycin C: 5.62 ± 3.96 months Gender: trabeculotomy: 11/14 (78.6%) boys and 3/14 (21.4%) girls; combined trabeculotomy–trabeculectomy with mitomycin C: 11/14 (78.6%) boys and 3/14 (21.4%) girls Inclusion criteria: primary congenital glaucoma in the first two years of life with no previous ocular surgeries Exclusion criteria: any childhood glaucoma other than primary congenital glaucoma Equivalence of baseline characteristics: "There was no significant difference between both groups regarding age and gender" |
|
Interventions |
Intervention 1: trabeculotomy Standard trabeculotomy Intervention 2: combined trabeculotomy–trabeculectomy with mitomycin C Trabeculotomy‐trabeculectomy with mitomycin C (0.2 mg/mL)‐soaked pieces of microsponge 494 mm2 were applied under the scleral flap and the conjunctiva for four minutes. |
|
Outcomes |
Outcomes:
Intervals at which outcome assessed: month 1 and 6, year 1, 2, and 3. Issues with outcome assessment: none Adverse effects: yes |
|
Notes |
Type of study: published Funding: "This research received no specific grant from any funding agency in the public, commercial or not for‐profit sectors" Declaration of interest: not reported Study period: between January 2012 and September 2012 Clinical trial registry: not reported |
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | "Infants with proved congenital glaucoma were randomly (using random computer‐generated numbers) allocated to either group A (trabeculotomy) or group B (combined trabeculotomy–trabeculectomy with mitomycin C) under general anaesthesia." |
Allocation concealment (selection bias) | Unclear risk | Method of allocation concealment was not described. |
Masking of participants and personnel (performance bias) | Unclear risk | Masking of participants and study personnel was not reported. |
Masking of outcome assessment (detection bias) | Unclear risk | Masking of outcome assessors was not reported. |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Numbers of participants who were excluded or lost to follow‐up were not reported. |
Selective reporting (reporting bias) | Unclear risk | Neither protocol nor clinical registry was available. |
Other bias | Unclear risk | Conflicts of interest were not reported. |